


Ask a doctor about a prescription for GLIMEPIRIDE SANDOZ 2 mg TABLETS
Package Leaflet: Information for the Patient
Glimepiride Sandoz 2 mg Tablets EFG
Glimepiride Sandoz 4 mg Tablets EFG
Read this package leaflet carefully before you start taking this medicine, because it contains important information for you.
Contents of the package leaflet
Glimepiride is an orally active medication that lowers blood sugar levels. This medication belongs to a group of medications that lower blood sugar levels called sulfonylureas. Glimepiride causes an increase in the amount of insulin released by the pancreas. Then, insulin lowers your blood sugar levels.
What Glimepiride Sandoz is used for:
Glimepiride is used to treat a type of diabetes (type 2 diabetes mellitus) when diet, physical exercise, and weight reduction alone have not been able to control your blood sugar levels.
Do not take Glimepiride Sandozand talk to your doctor if:
Do not take this medicine if any of the above situations apply to you. If you are not sure, consult your doctor or pharmacist before taking Glimepiride Sandoz.
Warnings and precautions
Talk to your doctor or pharmacist before you start taking Glimepiride Sandoz if:
If you are not sure if any of the above situations apply to you, consult your doctor or pharmacist before taking Glimepiride Sandoz.
In patients who lack an enzyme called glucose-6-phosphate dehydrogenase, it may happen that hemoglobin levels decrease and red blood cells break (hemolytic anemia).
Information available on the use of glimepiride in people under 18 years of age is limited. Therefore, its use is not recommended in these patients.
Important information about hypoglycemia (low blood sugar)
If you are taking glimepiride, you may have hypoglycemia (low blood sugar). Below you will find more information about hypoglycemia, its signs, and treatment.
The following factors can increase the risk of you suffering from hypoglycemia:
Signs of hypoglycemia include:
If your blood sugar levels continue to drop, you may have severe confusion (delirium), suffer seizures, lose self-control, your breathing may be shallow, and your heart rate may slow down, and you may become unconscious. The clinical picture of a severe drop in blood sugar is similar to a stroke.
Treatment of hypoglycemia
In most cases, the symptoms of low blood sugar disappear very quickly when you take something sweet, such as sugar cubes, sweet juices, or sugary tea.
Therefore, you should always carry something sweet with you (for example, sugar cubes). Remember that artificial sweeteners are not effective. Please consult your doctor or go to the hospital if you do not recover after taking sugar or if the symptoms recur.
Blood tests
Your blood sugar and urine levels should be regularly checked. Your doctor may also ask you to have blood tests to check your blood cell count and see how your liver is working.
Children and adolescents
Glimepiride is not recommended for use in children under 18 years of age.
Taking Glimepiride Sandoz with other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medications. Your doctor may want to change your dose of glimepiride if you are taking other medications that may increase or decrease the effect of glimepiride on your blood sugar levels.
The following medications may increase the blood sugar-lowering effect of glimepiride. This may lead to a risk of hypoglycemia (low blood sugar):
The following medications may decrease the blood sugar-lowering effect of glimepiride. This may lead to a risk of hyperglycemia (high blood sugar):
(estrogens, progestogens),
The following medications may increase or decrease blood sugar levels by decreasing the effect of glimepiride:
Glimepiride may also increase or decrease the effects of the following medications:
Colesevelam, a medication used to lower cholesterol, affects the absorption of glimepiride. To avoid this effect, it is recommended to take glimepiride at least 4 hours before colesevelam.
Taking Glimepiride Sandoz with alcohol
Consuming alcohol may increase or decrease the hypoglycemic effect of glimepiride in an unpredictable way.
Pregnancy and breastfeeding
Pregnancy
Glimepiride should not be taken during pregnancy.
Breastfeeding
Glimepiride may pass into breast milk. Glimepiride should not be used during the breastfeeding period.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and using machines
Your ability to concentrate or react may be impaired if your blood sugar levels drop (hypoglycemia) or rise (hyperglycemia) or if you have vision problems as a result of these conditions. Keep in mind that this puts you and others at risk (e.g., when driving or operating machinery). Please ask your doctor if you can drive if:
Glimepiride Sandoz contains lactose and sodium
If your doctor has told you that you have an intolerance to certain sugars, consult them before taking this medicine.
This medication contains less than 23 mg of sodium (1 mmol) per tablet, which is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Taking this medicine
How much to take
The dose of glimepiride depends on your needs, condition, and results of your blood sugar and urine tests, and will be determined by your doctor. Do not take more tablets than your doctor has prescribed.
If you take more Glimepiride Sandoz than you should
If you have taken too much glimepiride or a higher dose, there is a risk of hypoglycemia (see symptoms of hypoglycemia in section 2), and therefore, you should immediately consume enough sugar (e.g., sugar cubes, sweet juices, sugary tea) and inform your doctor immediately). When treating hypoglycemia due to accidental ingestion in children, the amount of sugar to be administered should be carefully controlled to avoid the possibility of producing dangerous hyperglycemia. Unconscious persons should not be given food or drink.
Since hypoglycemia can continue for a while, it is very important that the patient is carefully monitored until there is no more danger. It may be necessary to take safety measures, such as hospitalization. Show the package or remaining tablets to the doctor so they can see what you have taken.
Severe cases of hypoglycemia accompanied by loss of consciousness and severe neurological failure are medical emergencies that require immediate medical treatment and hospital admission. It should be ensured that there is always an informed person who can call a doctor in case of an emergency.
If you have taken more Glimepiride Sandoz than you should, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used.
If you forget to take Glimepiride Sandoz
Do not take a double dose to make up for forgotten doses.
If you stop taking Glimepiride Sandoz
If you stop or abandon treatment, keep in mind that the desired effect of lowering blood sugar will not be achieved, or the disease will worsen again. Continue taking glimepiride until your doctor tells you to stop.
If you have any further questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
Consult your doctor immediately if you suffer from any of the following symptoms:
Some patients have suffered the following adverse effects while taking glimepiride:
Rare Adverse Effects(may affect up to 1 in 1,000 patients)
Generally, these alterations disappear when treatment with glimepiride is interrupted.
Very Rare Adverse Effects(may affect up to 1 in 10,000 patients)
Adverse Effects of Unknown Frequency (cannot be estimated from available data)
Reporting Adverse Effects:
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of sight and reach of children.
Do not use this medicine after the expiration date that appears on the blister, bottle, and carton after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C.
Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the SIGRE Point in your pharmacy. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This way, you will help protect the environment.
Composition of Glimepirida Sandoz
The active ingredient is glimepiride.
Glimepirida Sandoz 2 mg: each tablet contains 2 mg of glimepiride.
Glimepirida Sandoz 4 mg: each tablet contains 4 mg of glimepiride.
The other components are:
Glimepirida Sandoz 2 mg: lactose monohydrate, sodium carboxymethyl starch (type A), povidone K30, yellow iron oxide (E172), carmine indigo (E132), microcrystalline cellulose, and magnesium stearate.
Glimepirida Sandoz 4 mg: lactose monohydrate, sodium carboxymethyl starch (type A), povidone K30, carmine indigo (E132), microcrystalline cellulose, and magnesium stearate.
Appearance of the Product and Package Contents
Glimepirida Sandoz 2 mg: green, slightly speckled, oblong, flat tablet with beveled edges, scored on both sides, and marked with 'G2' on one side.
Glimepirida Sandoz 4 mg: blue, slightly speckled, oblong, flat tablet with beveled edges, scored on both sides, and marked with 'G4' on one side.
The tablets are packaged in PVC/PE/PVDC/Aluminum blisters or PP bottles with LDPE or MDPE caps inside a carton, or in PP containers with LDPE or MDPE caps.
Package sizes:
Blister: 7, 14, 15, 20, 28, 30, 56, 60, 90, 98, 100, 120, and 100x1 tablets.
Bottle: 100 and 250 tablets.
Not all package sizes may be marketed.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Lek Pharmaceuticals d.d.
Verovškova 57, 1526 Ljubljana
Slovenia
or
LEK S.A.
ul. Podlipie 16, 95-010 Stryków
Poland
or
LEK S.A.
ul. Domaniewska 50 C, 02-672 Warszawa
Poland
or
Salutas Pharma GmbH
Otto von Guericke Allee 1, 39179 Barleben
Germany
This medicine is authorized in the Member States of the European Economic Area under the following names:
Austria: Glimepirid Sandoz 2 mg – Tabletten
Czech Republic: Glimepirid Sandoz
Denmark: Glimepirid Sandoz
Finland: Glimepirid Sandoz 2mg tablets
Glimepirid Sandoz 4mg tablets
Slovenia: Glimepirid LEK 2 mg tablets
Glimepirid LEK 4 mg tablets
Slovakia: Glimepirid Sandoz 2 mg
Glimepirid Sandoz 4 mg
Date of the last revision of this leaflet: February 2020.
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/
The average price of GLIMEPIRIDE SANDOZ 2 mg TABLETS in November, 2025 is around 10.18 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for GLIMEPIRIDE SANDOZ 2 mg TABLETS – subject to medical assessment and local rules.